-
Study aim
-
To determine the effect of prophylactic melatonin administration on the incidence of postoperative delirium in diabetic elderly patients undergoing orthopedic surgery under general anesthesia.
-
Design
-
A randomized, double blind, placebo controlled, parallel group clinical trial (Phase 3) with a sample size of 100 patients (50 per group). Simple randomization will be performed using a computer generated random number table.
-
Settings and conduct
-
The study will be conducted in the orthopedic surgery wards and the Post Anesthesia Care Unit (PACU) of a single hospital. Participants, surgeons, anesthesiologists, nursing staff, and outcome assessors are blinded to the group assignments. Allocation concealment is maintained using coded medication packages. Delirium assessments will be performed using the Confusion Assessment Method for the Intensive Care Unit (CAM ICU) and Memorial Delirium Assessment Scale (MDAS).
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients aged 60 years or older with confirmed diabetes mellitus, candidates for elective orthopedic surgery under general anesthesia, Abbreviated Mental Test (AMT) score of 8 or higher, and willing to provide informed consent. Exclusion criteria: History of using medications with known interactions with melatonin (e.g., warfarin), known allergy to melatonin, severe cognitive impairment, or severe hepatic and renal impairment.
-
Intervention groups
-
Intervention group: Receiving 5 mg oral melatonin capsules at 21:00 the night before surgery, 30 minutes before anesthesia induction, and at 21:00 for three consecutive nights postoperatively. Control group: Receiving identically appearing placebo capsules at the exact same time points.
-
Main outcome variables
-
Incidence of postoperative delirium (based on CAM ICU criteria); severity of postoperative delirium (based on MDAS scale); duration of delirium; length of hospital stay.